International Journal of Gynecological Cancer, 1048-891X

Journal

More filtering options
  1. 2020
  2. Ultrasound, macroscopic and histological features of malignant ovarian tumors

    Francesca Moro, Valeria Verdecchia, Paola Romeo, Francesca Ciccarone, Gian Franco Zannoni, Lil Valentin, Dirk Timmerman, Tom Bourne, Wouter Froyman, Giovanni Scambia & Antonia Carla Testa, 2020 Jan 1, In : International Journal of Gynecological Cancer. 001435.

    Research output: Contribution to journalArticle

  3. 2019
  4. Can we extend the indication for sentinel node biopsy in vulvar cancer? A nationwide feasibility study from Sweden

    Diana Zach, Paivi Kannisto, Katja Stenström Bohlin, Louise Moberg & Preben Kjölhede, 2019 Dec 2, In : International Journal of Gynecological Cancer.

    Research output: Contribution to journalArticle

  5. Robot-assisted approach to cervical cancer (RACC): An international multi-center, open-label randomized controlled trial

    Henrik Falconer, Kolbrun Palsdottir, Karin Stalberg, Pernilla Dahm-Kähler, Ulrika Ottander, Evelyn Serreyn Lundin, Lena Wijk, Rainer Kimmig, Pernille Tine Jensen, Ane Gerda Zahl Eriksson, Johanna Mäenpää, Jan Persson & Sahar Salehi, 2019 Jul 1, In : International Journal of Gynecological Cancer. 29, 6, p. 1072-1076 5 p.

    Research output: Contribution to journalArticle

  6. GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study

    Debora Verri, Tina Pasciuto, Elisabeth Epstein, Robert Fruscio, Floriana Mascilini, Francesca Moro, Giovanni Scambia, Lil Valentin & Antonia Carla Testa, 2019, In : International Journal of Gynecological Cancer.

    Research output: Contribution to journalArticle

  7. 2013
  8. Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type: The PaLiDo Study, a Phase II Nonrandomized Multicenter Study.

    Karina Dahl Steffensen, Marianne Waldstrøm, Niels Pallisgård, Bente Lund, Kjell Bergfeldt, Jessica Wihl, Nina Keldsen, Christian Marth, Ignace Vergote & Anders Jakobsen, 2013, In : International Journal of Gynecological Cancer. 23, 1, p. 73-80

    Research output: Contribution to journalArticle

  9. 2011
  10. Central nervous system metastases from epithelial ovarian cancer: Prognostic factors and outcome

    Gennaro Cormio, Vera Loizzi, Maddalena Falagario, Antonio Calace, Antonio Colamaria, Antonio De Tommasi & Luigi E. Selvaggi, 2011 Jun 1, In : International Journal of Gynecological Cancer. 21, 5, p. 816-821

    Research output: Contribution to journalArticle

  11. 2010
  12. Adjuvant chemotherapy in endometrial cancer.

    Thomas Högberg, 2010, In : International Journal of Gynecological Cancer. 20, 11 Suppl 2, p. S57-S59

    Research output: Contribution to journalArticle

  13. 2009
  14. Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.

    Emir Henic, Vera Casslén, Gunilla Høyer-Hansen, Stefan Hansson & Bertil Casslén, 2009, In : International Journal of Gynecological Cancer. 19, 2, p. 214-222

    Research output: Contribution to journalArticle

  15. 2008
  16. Response to letter of Escobar et al.

    Katarina Bartuma, Susanne Malander & Mef Nilbert, 2008, In : International Journal of Gynecological Cancer. 18, p. 1386-1386

    Research output: Contribution to journalArticle

  17. Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up

    B. Sorbe, H. Andersson, K. Boman, P. Rosenberg & Mårten Kalling, 2008, In : International Journal of Gynecological Cancer. 18, 4, p. 803-808

    Research output: Contribution to journalArticle

  18. 2007
  19. 2006
  20. Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta

    P. Petignat, Ricardo Laurini, F. Goffin, I. Bruchim & P. Bischof, 2006, In : International Journal of Gynecological Cancer. 16, 4, p. 1679-1684

    Research output: Contribution to journalArticle

  21. 2004
  22. 2003
  23. First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

    GB Kristensen, I Vergote, G Stuart, JM Del Campo, J Kaern, AB Lopez, E Eisenhauer, E Aavall-Lundquist, Mona Ridderheim, H Havsteen, MR Mirza, M Scheistroen & E Vrdoljak, 2003, In : International Journal of Gynecological Cancer. 13, p. 172-177

    Research output: Contribution to journalArticle

  24. 2002
  25. TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

    Anjila Koul, Pär-Ola Bendahl, Åke Borg, Mårten Fernö, MF Lidebring, T Hogberg, EL Einarsson, Mona Ridderheim & R Willen, 2002, In : International Journal of Gynecological Cancer. 12, 4, p. 362-371

    Research output: Contribution to journalArticle

  26. 2000
  27. BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features

    A. Koul, S. Malander, N. Loman, T. Pejovic, S. Heim, R. Willen, O. Johannsson, H. Olsson, M. Ridderheim & Å. Borg Å, 2000, In : International Journal of Gynecological Cancer. 10, 4, p. 289-295 7 p.

    Research output: Contribution to journalArticle

  28. 1995
  29. Identification of small areas of solid growth has a strong prognostic impact in differentiated endometrial carcinomas. A histopathologic and morphometric study

    P. Alm, T. Gudmundsson, R. Mårtensson, H. Anderson, G. Horvath & T. Högberg, 1995 Mar, In : International Journal of Gynecological Cancer. 5, 2, p. 87-93 7 p.

    Research output: Contribution to journalArticle

  30. 1992
  31. Nuclear morphometry: a strong prognostic factor for survival after secondary surgery in advanced ovarian cancer

    T. Högberg, G. Wang, B. Risberg, C. Guerrieri, J. Hittson, B. Boeryd, B. K>gedal & E. Simonsen, 1992 Jul, In : International Journal of Gynecological Cancer. 2, 4, p. 198-206

    Research output: Contribution to journalArticle